Standard smoking cessation services in sites participating in the SCIMITAR+ trial for people with severe mental ill health

Paul Heron*, Tayla Mccloud, Catherine Arundel, Della Bailey, Suzy Ker, Jinshuo Li, Masuma Mishu, David Osborn, Steve Parrott, Emily Peckham, Alison Stribling, Simon Gilbody

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Aims and method The SCIMITAR+ trial was commissioned to evaluate the effectiveness of a bespoke smoking cessation intervention for people with severe mental ill health compared with usual services. It is difficult to define what constitutes usual care in smoking cessation services. We aimed to define what this was during the trial. Twenty-two National Health Service healthcare providers participated in a bespoke survey asking about usual care in their area.Results All sites offered smoking cessation support; however, service provider and service type varied substantially. In some cases services were not streamlined, meaning that people received smoking cessation counselling from one organisation and smoking cessation medication from another.Clinical implications To better implement the National Institute for Health and Care Excellence guideline PH48, clearer referral pathways need to be implemented and communicated to patients, staff and carers. People with severe mental ill health need to be able to access services that combine nicotine replacement therapy and behavioural support in a streamlined manner.

Original languageEnglish
Pages (from-to)6-11
Number of pages6
JournalBJPsych bulletin
Issue number1
Early online date4 Jun 2019
Publication statusPublished - 2020

Bibliographical note

Funding Information:
This study was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (project number 11/136/52). S.G. was funded by the NIHR Collaboration for Leadership in Applied Health Research and Care Yorkshire and Humber. The views and opinions expressed herein are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health and Social Care. D.O. is supported by the University College London Hospitals NIHR Biomedical Research Centre, and he was also in part supported by the NIHR Collaboration for Leadership in Applied Health Research and Care, North Thames at Bart's Health National Health Service Trust.

Publisher Copyright:
© Copyright The Authors 2019.


  • bipolar affective disorders
  • nicotine replacement therapy
  • schizophrenia
  • Severe mental ill health
  • smoking cessation

Cite this